The Metabolic Testing Market Worth $475.75 Million by 2019

DALLAS, March 19, 2015 /PRNewswire/ --

According to a new market research report "Metabolic Testing Market by Product (CPET, Body Composition Analysis, ECG, Portable System), by Application (Critical Care, Lifestyle Diseases), by Technology (REE, Body Composition Analysis), by End User (Gym, Sports, Hospital) - Global Forecast to 2019 ", published by MarketsandMarkets, the Metabolic Testing Market is expected to reach around $475.75 Million by 2019 with a CAGR of around 7.41% during the forecast period (2014 to 2019).

Browse 68 market data tables and 88 figures spread through 150 pages and in-depth TOC on "Metabolic Testing Market"

http://www.marketsandmarkets.com/Market-Reports/metabolic-testing-equipment-market-149228862.html  

Early buyers will receive 10% customization on this report. 

According to estimates from the World Bank, the global healthcare spending increased from $3,770.14 Billion in 2003 to $7,163.64 Billion in 2012, at a CAGR of 7.39%. During this period, the public healthcare spending increased at a CAGR of 7.82%, from $2,182.47 Billion in 2003 to $4,285.10 Billion in 2012. On the other hand, the global population increased at a CAGR of 1.19%, from 6,302 Million in 2003 to 7,008 Million in 2012. The per capita healthcare spending also increased from $598 in 2003 to $1,022 in 2012, at a CAGR of 6.13%. Increase in healthcare expenditure is an important growth driver for the metabolic testing market.

Inquiry before Buying:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=149228862

The global Metabolic Testing Market is expected to reach $475.75 Million by 2019 from $332.78 Million in 2014, growing at a CAGR of 7.41% from 2014 to 2019. Rising prevalence of lifestyle diseases is the primary growth driver for this market during the forecast period (2014-2019). Moreover, technological advancements and increasing healthcare expenditure are also expected to drive market growth. However, high cost of equipment and software and reimbursement may hinder the growth of this market.

The global metabolic testing market is segmented on the basis of products, technologies, and applications. CPET system was the largest product segment while VO₂ max analysis was the largest technology segment in 2014. VO₂ max assessment is an important parameter for metabolic testing and is one of the most widely prescribed metabolic tests for athletes, healthy individuals, as well as patients. The lifestyle diseases application segment accounted for the largest share of the global metabolic testing market owing to the rising prevalence of lifestyle diseases such as cardiovascular diseases, diabetes, and obesity.

The major players of Metabolic Testing Market are CareFusion Corporation (U.S.), MGC Diagnostics Corporation (U.S.), COSMED (Italy), CORTEX Biophysik GmbH (Germany), Geratherm Medical AG (Germany), General Electric Company (U.S.), OSI Systems, Inc. (U.S.), KORR Medical Technologies, Inc. (U.S.), AEI Technologies, Inc. (U.S.), Parvo Medics (U.S.), and Microlife Medical Home Solutions, Inc. (U.S.).

Browse Related Reports:  

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

Cardiac Monitoring & Cardiac Rhythm Management (CRM) Market [ECG, Implantable Loop Recorder, Holter, Implantable Cardioverter Defibrillator (ICD), Automated External Defibrillator (AED), Pacemaker, CRT-D, CRT- P] - Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/cardiac-monitoring-advanced-technologies-and-global-market-55.html

About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain  @  http://www.marketsandmarkets.com/Subscription.html

Contact: 

Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets